PL2053408T3 - Sposób strukturalnego charakteryzowania rekombinowanego poliklonalnego białka lub poliklonalnej linii komórkowej - Google Patents

Sposób strukturalnego charakteryzowania rekombinowanego poliklonalnego białka lub poliklonalnej linii komórkowej

Info

Publication number
PL2053408T3
PL2053408T3 PL09151073T PL09151073T PL2053408T3 PL 2053408 T3 PL2053408 T3 PL 2053408T3 PL 09151073 T PL09151073 T PL 09151073T PL 09151073 T PL09151073 T PL 09151073T PL 2053408 T3 PL2053408 T3 PL 2053408T3
Authority
PL
Poland
Prior art keywords
polyclonal
cell line
structural characterization
procedure
recombinant
Prior art date
Application number
PL09151073T
Other languages
English (en)
Inventor
Lone Rasmussen
Torben Frandsen
Soren Rasmussen
Peter Andersen
Original Assignee
Symphogen As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphogen As filed Critical Symphogen As
Publication of PL2053408T3 publication Critical patent/PL2053408T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/96—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Document Processing Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL09151073T 2004-07-20 2005-07-20 Sposób strukturalnego charakteryzowania rekombinowanego poliklonalnego białka lub poliklonalnej linii komórkowej PL2053408T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200401133 2004-07-20
DKPA200401991 2004-12-22
EP09151073A EP2053408B1 (en) 2004-07-20 2005-07-20 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
EP05760790A EP1787126B1 (en) 2004-07-20 2005-07-20 A procedure for characterization of a polyclonal cell line

Publications (1)

Publication Number Publication Date
PL2053408T3 true PL2053408T3 (pl) 2012-08-31

Family

ID=35427551

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09151073T PL2053408T3 (pl) 2004-07-20 2005-07-20 Sposób strukturalnego charakteryzowania rekombinowanego poliklonalnego białka lub poliklonalnej linii komórkowej
PL05760790T PL1787126T3 (pl) 2004-07-20 2005-07-20 Sposób charakteryzowania poliklonalnej linii komórkowej

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL05760790T PL1787126T3 (pl) 2004-07-20 2005-07-20 Sposób charakteryzowania poliklonalnej linii komórkowej

Country Status (18)

Country Link
US (2) US8288109B2 (pl)
EP (2) EP2053408B1 (pl)
JP (1) JP4870667B2 (pl)
KR (1) KR101319848B1 (pl)
AT (2) ATE548657T1 (pl)
AU (1) AU2005263334C1 (pl)
BR (1) BRPI0513714A (pl)
CA (1) CA2574146C (pl)
DE (1) DE602005016818D1 (pl)
DK (2) DK1787126T3 (pl)
ES (2) ES2332524T3 (pl)
IL (2) IL180169A (pl)
MX (1) MX2007000551A (pl)
NO (1) NO20070931L (pl)
NZ (1) NZ552264A (pl)
PL (2) PL2053408T3 (pl)
RU (1) RU2426795C2 (pl)
WO (1) WO2006007853A2 (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1583830T1 (sl) * 2003-01-07 2006-12-31 Symphogen As Postopek za pripravo rekombinantnih poliklonskih proteinov
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
US8288109B2 (en) 2004-07-20 2012-10-16 Symphogen A/S Procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
EA014182B1 (ru) 2004-07-20 2010-10-29 Симфоген А/С КОМПОЗИЦИЯ ПОЛИКЛОНАЛЬНЫХ АНТИ-RhD АНТИТЕЛ, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ КОМПОЗИЦИИ
US7850965B2 (en) 2005-12-05 2010-12-14 Symphogen A/S Anti-orthopoxvirus recombinant polyclonal antibody
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
DK2121920T3 (da) * 2007-03-01 2011-11-21 Symphogen As Fremgangsmåde til kloning af sammenhørende antistoffer
BRPI0808551B1 (pt) 2007-03-01 2022-04-05 Symphogen A/S Composições de anticorpo para o receptor do fator de crescimento antiepidérmico recombinante, molécula de ligação bi-específica e composição farmacêutica que os compreende
JP2010534057A (ja) * 2007-03-06 2010-11-04 シムフォゲン・アクティーゼルスカブ 呼吸器合胞体ウイルス感染症を治療するための組換え抗体
CA2680792A1 (en) * 2007-03-15 2008-09-18 Biogen Idec Ma Inc. Treatment of autoimmune disorders
JP2008289483A (ja) * 2007-05-25 2008-12-04 Symphogen As 真核生物系において発現可能な形質転換体のスクリーニング
MX2009012526A (es) * 2007-05-25 2009-12-09 Symphogen As Metodo para fabricar una proteina policlonal recombinante.
CA2695309A1 (en) * 2007-09-07 2009-03-12 Symphogen A/S Methods for recombinant manufacturing of anti-rsv antibodies
RU2476886C2 (ru) * 2007-11-22 2013-02-27 Симфоген А/С Способ характеризации рекомбинантного поликлонального белка
NZ588651A (en) * 2008-04-23 2012-04-27 Symphogen As Methods for manufacturing a polyclonal protein
WO2010022736A2 (en) 2008-08-29 2010-03-04 Symphogen A/S Recombinant anti-epidermal growth factor receptor antibody compositions
CN102137928A (zh) * 2008-08-29 2011-07-27 西福根有限公司 克隆禽源抗体的方法
US8821879B2 (en) 2009-09-04 2014-09-02 Xoma Technology Ltd. Anti-botulism antibody coformulations
MX2012003538A (es) * 2009-10-09 2012-08-03 Symphogen As Cuantificacion multiple de proteinas recombinantes individuales en una mezcla mediante peptidos distintivos y espectrometria de masas.
US8987419B2 (en) * 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
MX347981B (es) 2010-11-01 2017-05-22 Symphogen As Composicion de anticuerpos pan-her.
US9790269B2 (en) 2013-02-08 2017-10-17 Misfolding Diagnostics, Inc. Transthyretin antibodies and uses thereof
US12546782B2 (en) * 2013-03-15 2026-02-10 Mayo Foundation For Medical Education And Research Identification and monitoring of monoclonal immunoglobulins related to monoclonal gammopathy by molecular mass with mass spectrometry
UY35517A (es) 2013-04-04 2014-10-31 Mabxience S A Un procedimiento para aumentar la formación de ácido piroglutamico de una proteína
WO2015093925A1 (es) * 2013-12-19 2015-06-25 CASTRO ALDRETE, Jorge Isaac Método de producción de anticuerpos específicos
TW201623331A (zh) * 2014-03-12 2016-07-01 普羅帝納生物科學公司 抗黑色素瘤細胞黏著分子（ｍｃａｍ）抗體類及使用彼等之相關方法
WO2018031887A1 (en) * 2016-08-12 2018-02-15 Abreos Biosciences, Inc. Detection and quantification of natalizumab
GB201710691D0 (en) * 2017-07-04 2017-08-16 Ge Healthcare Bio Sciences Ab Method in bioprocess purification system
EP3810649A1 (en) * 2018-06-22 2021-04-28 Genmab A/S Method for producing a controlled mixture of two or more different antibodies
CN112816595A (zh) * 2021-01-06 2021-05-18 海默斯（重庆）医学生物技术有限公司 一种重组角蛋白液体制剂及其纯度检测方法
AU2024323936A1 (en) * 2023-08-15 2026-04-02 Gigagen, Inc. Methods of analyzing recombinant polyclonal proteins

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002413A1 (en) 1983-11-28 1985-06-06 The Board Of Trustees Of The Leland Stanford Jr. U HUMAN MONOCLONAL ANTIBODY AGAINST Rh(D) ANTIGEN AND ITS USES
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
CA1293460C (en) 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
US5126130A (en) * 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a
GB8722020D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722019D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722018D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
EP0368684B2 (en) 1988-11-11 2004-09-29 Medical Research Council Cloning immunoglobulin variable domain sequences.
GB8906129D0 (en) 1989-03-17 1989-05-04 Central Blood Lab Authority Pharmaceutical preparations
GB8919761D0 (en) 1989-09-01 1989-10-18 Central Blood Lab Authority Chemical compounds
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
BR9305557A (pt) 1992-06-26 1997-03-25 Aetsrn Anticorpos monoclonais humanos anti Rhesus-D e composiçao farmacêutica que os contém
US5538848A (en) * 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
DE69534347T2 (de) 1994-01-31 2006-05-24 Trustees Of Boston University, Boston Bibliotheken aus Polyklonalen Antikörpern
FR2724182B1 (fr) * 1994-09-02 1996-12-13 Pasteur Institut Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations
US6111166A (en) 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
AU722127B2 (en) 1996-06-24 2000-07-20 Zlb Behring Ag Polypeptides capable of forming antigen binding structures with specificity for the rhesus D antigens, the DNA encoding them and the process for their preparation and use
US6255455B1 (en) * 1996-10-11 2001-07-03 The Trustees Of The University Of Pennsylvania Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
US5876925A (en) * 1996-10-11 1999-03-02 The Trustees Of The University Of Pennsylvania Magnetically activated cell sorting for production of proteins
AU737155B2 (en) 1997-03-14 2001-08-09 Biogen Idec Inc. Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
JPH11174038A (ja) * 1997-12-10 1999-07-02 Tosoh Corp 蛋白質の分離精製法
WO2000011155A1 (en) 1998-08-19 2000-03-02 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for genomic modification
US20020155114A1 (en) * 1998-08-31 2002-10-24 James D. Marks Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
US6395538B1 (en) * 1999-07-16 2002-05-28 Human Genome Sciences, Inc. Method and system for providing real-time, in situ biomanufacturing process monitoring and control in response to IR spectroscopy
DK1234022T3 (da) 1999-07-23 2010-07-19 Univ California DNA-rekombination i eukaryote celler med bakteriofag PHIC31-rekombinationssystemet
EP1106625A1 (en) 1999-11-17 2001-06-13 ZLB Bioplasma AG Rhesus D specific peptide sequences
CA2401663C (en) 2000-02-08 2008-11-25 The Regents Of The University Of Michigan Protein mapping
WO2001058925A2 (en) 2000-02-08 2001-08-16 The Regents Of The University Of Michigan Protein separation and display
US7069151B2 (en) 2000-02-08 2006-06-27 Regents Of The University Of Michigan Mapping of differential display of proteins
HK1052305B (en) 2000-05-26 2007-10-12 Symphogen A/S Recombinant or purified polyclonal antibodies for treating allergy
US6610472B1 (en) * 2000-10-31 2003-08-26 Genetastix Corporation Assembly and screening of highly complex and fully human antibody repertoire in yeast
JP2004514444A (ja) * 2000-11-28 2004-05-20 アプライド　モレキュラー　エボリューション，　インコーポレイテッド 二重ｌｏｘ組換えに基づく真核生物発現ライブラリーおよび使用方法
EP1739424B1 (en) * 2000-12-26 2011-08-24 The Institute for Systems Biology Rapid and quantitative proteome anaysis and related methods
US7541003B2 (en) * 2001-07-17 2009-06-02 Bio-Rad Laboratories, Inc. Latex based adsorbent chip
WO2003054549A2 (en) * 2001-12-08 2003-07-03 Micromass Uk Limited Method of mass spectrometry
US20040033591A1 (en) 2002-05-31 2004-02-19 The Regents Of The University Of Michigan Automated protein analysis system
DK2314629T4 (da) * 2002-07-18 2023-02-06 Merus Nv Rekombinant produktion af blandinger af antistoffer
JP2004101477A (ja) * 2002-09-12 2004-04-02 Yoshio Yamauchi ２次元高速液体クロマトグラフ装置及びそれを用いた蛋白質分析装置
AU2003284227A1 (en) 2002-10-15 2004-05-04 The Regents Of The University Of Michigan Multidimensional protein separation system
US20060275766A1 (en) * 2003-01-07 2006-12-07 Haurum John S Method for manufacturing recombinant polyclonal proteins
SI1583830T1 (sl) 2003-01-07 2006-12-31 Symphogen As Postopek za pripravo rekombinantnih poliklonskih proteinov
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
EA014182B1 (ru) 2004-07-20 2010-10-29 Симфоген А/С КОМПОЗИЦИЯ ПОЛИКЛОНАЛЬНЫХ АНТИ-RhD АНТИТЕЛ, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ КОМПОЗИЦИИ
US8288109B2 (en) 2004-07-20 2012-10-16 Symphogen A/S Procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
US7850965B2 (en) 2005-12-05 2010-12-14 Symphogen A/S Anti-orthopoxvirus recombinant polyclonal antibody
WO2007101441A1 (en) 2006-03-06 2007-09-13 Symphogen A/S Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
RU2476886C2 (ru) 2007-11-22 2013-02-27 Симфоген А/С Способ характеризации рекомбинантного поликлонального белка

Also Published As

Publication number Publication date
AU2005263334C1 (en) 2011-01-20
HK1133076A1 (en) 2010-03-12
DK2053408T3 (da) 2012-06-04
WO2006007853A2 (en) 2006-01-26
NZ552264A (en) 2010-03-26
US20130203063A1 (en) 2013-08-08
JP4870667B2 (ja) 2012-02-08
AU2005263334B2 (en) 2010-08-05
BRPI0513714A (pt) 2008-05-13
DE602005016818D1 (de) 2009-11-05
IL180169A (en) 2011-04-28
EP1787126B1 (en) 2009-09-23
PL1787126T3 (pl) 2010-03-31
EP2053408A3 (en) 2009-07-29
CA2574146A1 (en) 2006-01-26
EP2053408A2 (en) 2009-04-29
EP1787126A2 (en) 2007-05-23
AU2005263334A1 (en) 2006-01-26
ATE443870T1 (de) 2009-10-15
HK1101043A1 (en) 2007-10-05
DK1787126T3 (da) 2009-12-21
KR20070032078A (ko) 2007-03-20
IL180169A0 (en) 2007-06-03
IL203017A (en) 2013-08-29
ES2381531T3 (es) 2012-05-29
EP2053408B1 (en) 2012-03-07
JP2008506960A (ja) 2008-03-06
NO20070931L (no) 2007-04-17
MX2007000551A (es) 2007-03-30
WO2006007853A3 (en) 2006-05-18
CA2574146C (en) 2015-06-30
KR101319848B1 (ko) 2013-10-18
RU2007106050A (ru) 2008-08-27
US9029091B2 (en) 2015-05-12
RU2426795C2 (ru) 2011-08-20
ES2332524T3 (es) 2010-02-08
ATE548657T1 (de) 2012-03-15
US8288109B2 (en) 2012-10-16
US20080131882A1 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
IL180169A0 (en) A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
BRPI0507433C1 (pt) anticorpo monoclonal recombinante ou sua parte de ligação ao antígeno, composição, ácido nucleico isolado, vetor de expressão, e, kit
MX2010005377A (es) Metodo para caracterizacion de proteina policlonal recombinante.
NO922457L (no) Antistoffantagonister av humant interleukin-4
EA201000471A1 (ru) Антигенсвязывающие белки, способные связывать тимусный стромальный лимфопоэтин
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
EA200700751A1 (ru) Способы и композиции для улучшения продуцирования рекомбинантного белка
WO2005066867A3 (en) Modulators of cell-surface receptors of the ig-class
WO2006004663A3 (en) Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis
WO2009010539A3 (en) Receptor for interleukin-6 (il-6) from macaca fascicularis
WO2003046148A3 (en) Polypeptide quantitation
WO2024020590A3 (en) Antigen binding molecules targeting thymic stromal lymphopoietin (tslp)
DK1711531T3 (da) Neutraliserende anti-TLR4/-MD-2-antistoffer og fremgangsmåder til anvendelse deraf
WO2002065126A8 (en) Use of troponin i as a species marker protein for meat speciation in both raw and heat-processed products
DE602005013947D1 (de) Antikörper gegen hundepankreaslipase
WO2004084841A3 (en) Novel anti-feline albumin antibodies and methods of detecting early renal disease
ATE535546T1 (de) Humane monoklonale antikörper, die spezifisch an ifg-ii binden
Altinier et al. An IgE multiple myeloma: contradictory findings in clinical laboratory testing
WO2006005583A3 (en) Secreted polypeptide species involved in multiple sclerosis
ATE532796T1 (de) Immunassays zur spezifischen bestimmung von scca- isoformen
ATE476449T1 (de) Verwendung von endosialinbindenden proteinen zum isolieren endosialinpositiver zellen
WO2022018040A3 (en) Sars-cov-2 proteins, anti-sars-cov-2 antibodies, and methods of using the same
Mehand et al. Estimation of analyte concentration by surface plasmon resonance-based biosensing using parameter identification techniques
WO2006138694A3 (en) Rabbit monoclonal antibody against id1 protein
WO2024011061A3 (en) Compositions and methods to detect autoimmune antibodies